RadaHaim is a biotech company developing high-throughput organoid assay systems for drug discovery and preclinical testing. The company produces standardized 3D organoids and provides assay services for toxicity evaluation, mechanism-of-action analysis and drug-candidate validation. Its platform is designed to generate more human-relevant biological data and support alternatives to animal testing, helping pharmaceutical, biotech and research partners bridge early-stage research and clinical development.